An opportunity to work with an internationally recognized team of clinicians, epidemiologists, medical scientists and others
Study levels
Research
Student type
Future students
Study area
Health and community
What you'll receive
A scholarship, indexed annually of $40K per annum for 3 years, with the possibility of up to 1 year extension, will be provided to the successful applicant. The successful applicant will be required to apply for externally competitive scholarships during his/her candidature. A clinical loading may be negotiated.
How to apply
Submit your expression of interest to Dr Kerry-Ann O’Grady via email.
Your expression of interest must include:
If your expression of interest is accepted you will then need to formally submit your application for admission. Before submitting your application for submission please read through the eligibility requirements and application guide on the QUT website.
What happens next?
This scholarship will remain open until a suitable candidate is found.
For more information about the scholarship or application process please contact Dr Kerry-Ann O’Grady via email.
About the scholarship
The Cough, Asthma and Airways Research Group (CAARG) in the School of Public Health and Social Work and Institute of Health & Biomedical Innovation at QUT is seeking a medical degree graduate to undertake a PhD within a randomised controlled trial of a vaccine given in pregnancy and its role in preventing infant illnesses in the first 12 months of life (The PneuMatters Study).
The trial is funded by the National Health and Medical Research Council.
This PhD offers the opportunity to work with an internationally recognised team of clinicians, epidemiologists, medical scientists and others on a multi-centre-randomised controlled trial that addresses both maternal and child health in First Nations peoples. The successful candidate will be located at the Centre for Children’s Health Research in South Brisbane under the supervision of Professor Anne B Chang and Dr Kerry-Ann O’Grady. Other external supervisors may be engaged. The research is a collaboration with clinicians and researchers from Menzies School of Health Research, The University of Queensland, Griffith University, Sydney University, The University of Malaya, Royal Darwin Hospital, Logan Hospital, The Toowoomba Hospital, Royal Brisbane Hospital, Nganampa Health Council and Likas Hospital in Malaysia. The trial incorporates clinical, immunological, microbiological and safety endpoints.
You must have:
Aboriginal, Torres Strait Islander, Maori and/or Pacific Islander people are strongly encouraged to apply.
At NHMRC we are excited by the huge potential benefits of the research we fund and by the opportunities we have to ensure Australians have access to evidence-based, authoritative health advice.
We create pathways to a healthier future through our research funding, our health guidelines and the ethical standards we set and uphold.
As the nation’s leading expert body in health and medical research, we set ourselves high standards of integrity and scientific rigour, and see ourselves as championing the pursuit of better health outcomes for all Australians.
The NHMRC Corporate Plan 2019–20 covers the period 2019–20 to 2022–23. In line with the requirements of the National Health and Medical Research Council Act 1992, it identifies the major health issues for this period, how NHMRC will deal with these issues and a strategy for medical research and public health research.
Our strategy for health and medical research
The themes of investment, translation and integrity represent NHMRC’s strategy for health and medical research. NHMRC will:
Twitter
Add a Comment
Please do not post:
Thank you once again for doing your part to keep Edarabia the most trusted education source.